59 related articles for article (PubMed ID: 21972703)
1. [Prognostic value of the molecular markers ICAM-1 and C-JUN in patients with lung cancer].
Uchikov A; Dimitrov I; Hadjiev B; Prisadov G; Uchikova E; Ganchevska P
Khirurgiia (Sofiia); 2010; (1):36-9. PubMed ID: 21972703
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of estrogen receptors--ERalpha and ERbeta, in patients with lung cancer].
Uchikov A; Dimitrov I; Hadjiev B; Prisadov G; Uchikova E; Ganchevska P; Uzunova V
Khirurgiia (Sofiia); 2010; (1):32-5. PubMed ID: 21972702
[TBL] [Abstract][Full Text] [Related]
3. [Stage of disease as a prognostic factor in radically operated patients with non-small cell lung cancer].
Uchikov A; Hadjiev B; Dimitrov I; Murdjev K; Grudeva-Popova J; Prisadov G; Uchikova E; Paskalev G
Khirurgiia (Sofiia); 2010; (2-3):8-11. PubMed ID: 21972687
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of vascular endothelial growth factor and intercellular adhesion molecule-1 expression in non-small cell lung cancer].
Zhang HW; Zhang L; Chen JH; Du JJ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):354-7. PubMed ID: 15854337
[TBL] [Abstract][Full Text] [Related]
5. [Extent of resection as a prognostic factor in patients with non-small cell lung cancer].
Uchikov A; Dimitrov I; Hadjiev B; Grudeva-Popova J; Prisadov G; Uchikova E; Uzunova V; Paskalev G
Khirurgiia (Sofiia); 2010; (2-3):15-8. PubMed ID: 21972689
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of the molecular markers cyclin D1 and P53 in patients with lung cancer].
Uchikov A; Hadjiev B; Dimitrov I; Prisadov G; Uchikova E; Batashki A; Ganchevska P
Khirurgiia (Sofiia); 2010; (6):19-22. PubMed ID: 21972713
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
Yuan K; Qian C; Zheng R
Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
[TBL] [Abstract][Full Text] [Related]
9. [Histoligic type of the tumor as an independent factor for survival in non-small cell lung cancer].
Uchikov A; Staribratova D; Prisadov G; Uchikova E; Dimitrov I; Batashki A
Khirurgiia (Sofiia); 2009; (4-5):24-6. PubMed ID: 20506801
[TBL] [Abstract][Full Text] [Related]
10. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
Ferreira CG; van der Valk P; Span SW; Ludwig I; Smit EF; Kruyt FA; Pinedo HM; van Tinteren H; Giaccone G
Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
[TBL] [Abstract][Full Text] [Related]
11. Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
Ratto GB; Costa R; Maineri P; Alloisio A; Bruzzi P; Dozin B
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):849-58. PubMed ID: 19660370
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.
Lu C; Soria JC; Tang X; Xu XC; Wang L; Mao L; Lotan R; Kemp B; Bekele BN; Feng L; Hong WK; Khuri FR
J Clin Oncol; 2004 Nov; 22(22):4575-83. PubMed ID: 15542809
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
16. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
17. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
[TBL] [Abstract][Full Text] [Related]
19. [Sex as a prognostic factor for the patients with non-small cell lung cancer].
Uchikov A; Dimitrov I; Uchikova E; Prisadov G; Grigorov D; Staribratova D; Novakov I
Khirurgiia (Sofiia); 2009; (6):37-9. PubMed ID: 20506778
[TBL] [Abstract][Full Text] [Related]
20. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
